In premenopausal women with non-metastatic breast cancer, use of tamoxifen may nearly double the risk of endometrial cancer, researchers report.
Menopause after breast cancer can cause symptoms that substantially impact quality of life, making individualized, multidisciplinary care and shared decision-making critical, experts noted during ...
Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced that 11 studies featuring the Breast Cancer Index® (BCItm) Test will be presented at the 2025 San Antonio Breast Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback